In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020

Lee, YL; Ko, WC; Lee, WS; Lu, PL; Chen, YH; Cheng, SH; Lu, MC; Lin, CY; Wu, TS; Yen, MY; Wang, LS; Liu, CP; Shao, PL; Shi, ZY; Chen, YS; Wang, FD; Tseng, SH; Lin, CN; Chen, YH; Sheng, WH; Lee, CM; Tang, HJ; Hsueh, PR

Hsueh, PR (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.; Hsueh, PR (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021; 58 (3):

Abstract

This study examined the susceptibility of carbapenem-nonsusceptible Enterobacterales (CNSE) to cefiderocol, cefepime/zidebactam, cefepime/enmetazobact......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索